Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Trump administration cuts hit biotech sector, causing job losses and discouraging investments.

flag The Trump administration's cuts to federal health agencies have deepened the biotech sector's slump. flag Mass firings at the FDA and funding freezes from the NIH increase uncertainty for small and mid-cap biotech firms, impacting drug approvals and discouraging investment. flag The S&P Biotech ETF index hit an 18-month low, down 20% this year, with concerns over the FDA's ability to fulfill its role.

3 Articles

Further Reading